Agenda Item Title:
Approve Amended City DOT Drug/Alcohol Testing Policy to Reflect New DOT Opioid Testing Requirements
Origination Group:
Legal & Finance Committee
Origination Meeting Date:
01/31/2018
City Council Hearing Date:
02/05/2018
Staff Contact:
Trevor Schmelz, Risk Management
Agenda Item Summary:
Amended policy to add section 5.4) Effective January 1, 2018, The DOT required added testing for semi-synthetic opioids (i.e., hydrocodone, hydromorphone, oxymorphone, and oxycodone) to the panel. As this is a legal drug, if there is a positive result, the Medical Review Officer (MRO) will verify if there is a legitimate medical explanation for the results. If a valid prescription is available, it can be provided to the MRO for further review. If a legitimate medical explanation is established, the MRO will report the result to your employer as a ‘negative’. If not, the MRO will report the result to your employer as ‘positive’.
Funding Source & Fiscal Impact (if applicable):
| Funding | Cost Center |
|---|---|
Recommendations:
Origination Recommendation Action:
Approve